Evaluation of the antiviral activity of compound BCX-4430 against Ebola and Marburg viruses in vitro

Project: Other project

StatusFinished
Effective start/end date5/1/114/30/12

Funding

  • BioCryst Pharmaceuticals Incorporated: $6,967.00